Notice: This company has been marked as potentially delisted and may not be actively trading. Immuron (IMRN) News Today Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsCompetitorsHeadlinesShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Immuron Limited Issues New Unquoted Performance RightsOctober 29, 2024 | markets.businessinsider.comImmuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare ConferenceOctober 16, 2024 | globenewswire.comImmuron Limited: Immuron Travelan continued strong sales growthOctober 15, 2024 | finanznachrichten.deImmuron Travelan® continued strong sales growthOctober 15, 2024 | globenewswire.comImmuron turns in strong performance for Travelan® in September quarter, expands globallyOctober 14, 2024 | au.investing.comImmuron making inroads into the international market with flagship assets Travelan and IMM-529October 11, 2024 | au.investing.comImmuron (NASDAQ:IMRN) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comNMRC Reports Results for Campylobacter Controlled Human Infection Model StudyOctober 4, 2024 | globenewswire.comTraveler's Diarrhea Therapeutics Pipeline Market Report 2024 Featuring Immuron, Scandinavian Biopharma, and Sigmoid PharmaSeptember 19, 2024 | globenewswire.comImmuron Plans Phase 2 Trial for IMM-529 following FDA reviewSeptember 5, 2024 | globenewswire.comImmuron Limited (IMRN) Stock Price, News, Quote & History - Yahoo FinanceAugust 30, 2024 | ca.finance.yahoo.comImmuron Limited (IMRN)August 25, 2024 | finance.yahoo.comImmuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®August 16, 2024 | globenewswire.comBond investing making a comeback on rate cut forecasts: PanelAugust 16, 2024 | uk.finance.yahoo.comAI is being 'built into everything we're doing': Lenovo execAugust 16, 2024 | uk.finance.yahoo.comImmuron CEO, Steven Lydeamore to present at the Emerging Growth ConferenceAugust 15, 2024 | globenewswire.comImmuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct ConnectAugust 7, 2024 | globenewswire.comImmuron Limited (IMC.AX)August 4, 2024 | finance.yahoo.comImmuron requests pre-IND meeting for IMM-529 with FDA filingJuly 2, 2024 | globenewswire.comImmuron CEO, Steven Lydeamore to present at the Emerging Growth ConferenceJune 5, 2024 | globenewswire.comImmuron CEO Steven Lydeamore to present at Peak Sky HighMay 31, 2024 | globenewswire.comImmuron Board ChangesMay 31, 2024 | globenewswire.comImmuron Limited to Present at the Emerging Growth ConferenceMay 7, 2024 | globenewswire.comImmuron Director ResignationMay 3, 2024 | globenewswire.comImmuron Limited (IMRN) Interactive Stock Chart - Yahoo FinanceApril 15, 2024 | finance.yahoo.comImmuron to host Live Virtual EventApril 15, 2024 | globenewswire.comImmuron Limited: Immuron Travelan sales continued strong growthApril 10, 2024 | finanznachrichten.deImmuron gains after Travelan sales updateApril 10, 2024 | msn.comImmuron Travelan® sales continued strong growthApril 10, 2024 | globenewswire.comImmuron Limited (IMRN) Latest Stock News & Headlines - Yahoo FinanceMarch 27, 2024 | ca.finance.yahoo.comImmuron Ltd ADR (IMRN)March 22, 2024 | investing.comImmuron surges after mid-stage data for antidiarrheal medMarch 7, 2024 | msn.comImmuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the USMarch 7, 2024 | globenewswire.comASX Health Stocks: Immuron leaps 80pc after announcing that Travelan trials will move to Phase 3March 7, 2024 | msn.comTrading was temporarily halted for "IMRN" at 07:03 PM with a stated reason of "News pending."March 5, 2024 | marketbeat.comImmuron Stock (NASDAQ:IMRN) Dividends: History, Yield and DatesFebruary 22, 2024 | benzinga.comImmuron Presentation Australian Biologics Festival 2024February 21, 2024 | globenewswire.comImmuron Limited: Immuron achieves record Travelan salesFebruary 13, 2024 | finanznachrichten.deImmuron achieves record Travelan® salesFebruary 13, 2024 | finance.yahoo.comImmuron Limited: Immuron achieves record half yearly Travelan salesJanuary 16, 2024 | finanznachrichten.deImmuron achieves record half yearly Travelan® salesJanuary 16, 2024 | finance.yahoo.comASX Health Stocks: Immuron chalks up record half for travelers’ diarrhoea medicine, TravelanJanuary 15, 2024 | msn.comImmuron chalks up stellar half-year Travelan sales as travel returns to pre-pandemic levelsJanuary 15, 2024 | au.investing.comImmuron Clinical Trials UpdateDecember 22, 2023 | finance.yahoo.comImmuron enrols first patients in Campylobacter Challenge clinical studyDecember 4, 2023 | proactiveinvestors.comImmuron Announces First Patients Enrolled in Campylobacter Challenge Clinical StudyDecember 4, 2023 | markets.businessinsider.comImmuron CEO, Steven Lydeamore Investor Webinar PresentationNovember 28, 2023 | finance.yahoo.comImmuron CEO Steven Lydeamore Investor Webinar PresentationNovember 13, 2023 | finance.yahoo.comImmuron receives bull case valuation of A$0.35 from Pitt Street ResearchNovember 1, 2023 | au.investing.comImmuron receives bull case valuation of A$0.35 from Pitt Street...October 31, 2023 | proactiveinvestors.com Get Immuron News Delivered to You Automatically Sign up to receive the latest news and ratings for IMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here IMRN Media Mentions By Week IMRN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMRN News Sentiment▼0.000.53▲Average Medical News Sentiment IMRN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMRN Articles This Week▼20▲IMRN Articles Average Week Get Immuron News Delivered to You Automatically Sign up to receive the latest news and ratings for IMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IMMX News Today VTVT News Today RLYB News Today FBIO News Today PRPH News Today CLNN News Today CALC News Today NXTC News Today LUMO News Today LEXX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMRN) was last updated on 11/15/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immuron Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Immuron With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
